MAJOR DEPRESSIVE DISORDER, ANHEDONIA, AND AGOMELATINE: AN OPEN-LABEL STUDY

被引：0
|
作者：
Martinotti, G. [1 ,2 ]
Di Iorio, G. [2 ]
Guglielmo, R. [1 ]
De Berardis, D. [2 ]
Janiri, L. [1 ]
Di Giannantonio, M. [2 ]
机构：
[1] Univ Cattolica Sacro Cuore, Rome, Italy
[2] Univ G DAnnunzio, Chieti, Italy
来源：
EUROPEAN PSYCHIATRY | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
P02-55
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MAJOR DEPRESSIVE DISORDER, ANHEDONIA AND AGOMELATINE: AN OPEN-LABEL STUDY
    di Giannantonio, M.
    Di Iorio, G.
    Guglielmo, R.
    De Berardis, D.
    Conti, C. M.
    Acciavatti, T.
    Cornelio, M.
    Martinotti, G.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2011, 25 (01): : 109 - 114
  • [2] Major depressive disorder, sleep EEG and agomelatine: an open-label study
    Salva, Maria-Antonia Quera
    Vanier, Bernard
    Laredo, Judith
    Hartley, Sarah
    Chapotot, Florian
    Moulin, Catherine
    Lofaso, Frederic
    Guilleminault, Christian
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (05): : 691 - 696
  • [3] Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study
    Arango, Celso
    Fegert, Joerg M.
    Picarel-Blanchot, Francoise
    Marx, Ute
    Truffaut-Chalet, Lucie
    Penelaud, Pierre-Francois
    Buitelaar, Jan
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2024,
  • [4] Neural correlates of change in major depressive disorder anhedonia following open-label ketamine
    Lally, Niall
    Nugent, Allison C.
    Luckenbaugh, David A.
    Niciu, Mark J.
    Roiser, Jonathan P.
    Zarate, Carlos A., Jr.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (05) : 596 - 607
  • [5] Duloxetine in the treatment of major depressive disorder: an open-label study
    James I Hudson
    David G Perahia
    Inmaculada Gilaberte
    Fujun Wang
    John G Watkin
    Michael J Detke
    [J]. BMC Psychiatry, 7
  • [6] Duloxetine in the treatment of major depressive disorder: an open-label study
    Hudson, James I.
    Perahia, David G.
    Gilaberte, Inmaculada
    Wang, Fujun
    Watkin, John G.
    Detke, Michael J.
    [J]. BMC PSYCHIATRY, 2007, 7 (1) : 43
  • [7] AGOMELATINE IN CHILDREN AND ADOLESCENTS WITH MODERATE TO SEVERE MAJOR DEPRESSIVE DISORDER: 2-YEAR OPEN-LABEL EXTENSION STUDY
    Falissard, B.
    Buitelaar, J. K.
    Fegert, J. M.
    Penelaud, P. F.
    Marx, U.
    Picarel-Blanchot, F.
    Arango, C.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2023, 57 (01): : 138 - 138
  • [8] Agomelatine as monotherapy for major depression: an outpatient, open-label study
    Pecenak, Jan
    Novotny, Vladimir
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1595 - 1604
  • [9] Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder A Pilot Study
    Martinotti, Giovanni
    Sepede, Gianna
    Gambi, Francesco
    Di Iorio, Giuseppe
    De Berardis, Domenico
    Di Nicola, Marco
    Onofrj, Marco
    Janiri, Luigi
    Di Giannantonio, Massimo
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (04) : 487 - 491
  • [10] An open-label, flexible-dose study of memantine in major depressive disorder
    Ferguson, James M.
    Shingleton, Richard N.
    [J]. CLINICAL NEUROPHARMACOLOGY, 2007, 30 (03) : 136 - 144
12345